PCRX — Pacira Biosciences Share News
0.000.00%
Last trade - 00:00- $878.64m
- $1.04bn
- $726.41m
Brief: Pacira Biosciences Urges Stockholders To Vote "For" Election Of Pacira's Nominees On Blue Proxy Card
Brief: Doma Perpetual Urges Pacira Biosciences Shareholders To Judge Sale Price Adequacy
Brief: Doma Perpetual Capital Management Calls For Removal Of Pacira CEO And Strategic Sale
Brief: Pacira Biosciences Sends Letter To Stockholders Reiterating Superior Qualifications Of Its Board Nominees
Brief: Pacira Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Pacira Q1 revenue beats estimates, co raises 2026 outlook
U.S. STOCKS ON THE MOVE -Gyre Therapeutics, Nutrien Ltd, Rapid Micro Biosystems
U.S. STOCKS ON THE MOVE -Natera, Pacira BioSciences, Kezar Life Sciences
U.S. STOCKS ON THE MOVE-SciSparc, Natera, US energy companies
Pacira BioSciences rises as activist DOMA seeks board overhaul, CEO ouster
U.S. STOCKS ON THE MOVE-Agricultural stocks, Papa John's, Oil companies
Pacira rises as DOMA pushes for CEO ouster, board shake-up and sale
Brief: Pacira Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Pacira Biosciences Reports Fourth Quarter And Full-Year 2025 Financial Results
Pacira BioSciences Q4 revenue rises 5% yr/yr
Brief: Pacira Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Pacira Announces Agreement With Lg Chem To Make Exparel® Available In Select Asian-Pacific Markets
Pacira 2025 preliminary revenue slightly misses expectations
Brief: Doma Perpetual Capital Management Asserts Pacira Biosciences's Board To Pursue Sale Of Company